Hutch News
Results per Page:
One step closer to personalized oncology for chemo-resistant ovarian cancer
From the Paulovich Lab, Translational Science and Therapeutics Division
Big-picture approach helps identify experimental diagnostic to personalize ovarian cancer treatment
Team uses large-scale proteogenomic changes to identify which patients should look beyond standard treatment options
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
Paulovich Lab's proteomic platform presented at personalized medicine conference
Celebrating faculty and staff achievements
SCIEX to commercialize targeted proteomics technology developed in Paulovich Lab
Collaboration aims to make targeted proteomics in cancer research more reproducible, specific
Good News at Fred Hutch
<p>Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf</p>
$4.8 million federal stimulus grant launches feasibility study of massive endeavor to measure all human proteins
The ultimate goal is an undertaking analogous to the human genome project
Researchers identify biomarkers of early-stage pancreatic cancer in mice and man
Findings bring scientists a big step closer to developing a blood test for early detection